In this study, to determine FANC against atherosclerosis, we evaluated the therapeutic effects of FANC on reducing atherosclerotic plaque burden using apolipoprotein E (ApoE)-deficient mice and low density lipoprotein receptor (LDLR)-deficient mice fed high fat diet. The gene discussed is LDLR; the disease is atherosclerosis.